Lupin

Humrahi empowers patients with the knowledge and skills necessary for precise insulin injection techniques

First-ever product launch in the inhalation segment in Germany

Collaboration to enhance healthcare services, ensure timely diagnosis, and improve accessibility of healthcare services

It is currently available in 10 cities and can be availed by patients by reaching out to their consulting cardiologists

Through this agreement, Lupin will introduce two new formulations, a fixed-dose combination of Rifapentine + Isoniazid and…

Clinical data suggests that it is effective on patients with co-morbidities

Lupin intends to commercialise the anti-tuberculosis (TB) medicine in approximately 140 countries and territories, including many…

The platform is the latest initiative under Lupin’s long-running umbrella programme, Joint Airways Initiative (JAI), for patients…

While Lupin and Marksans Pharma are recalling diabetes drug, Aurobindo and Alembic are recalling psychiatric medication in the US…

To strengthen respiratory disease management facilities Medical device maker Omron Healthcare India has joined hands…